tradingkey.logo
搜索

Treace Medical Concepts Inc

TMCI
添加自选
4.310USD
-0.070-1.60%
收盘 07-31 16:00美东报价延迟15分钟
279.60M总市值
亏损市盈率 TTM

Treace Medical Concepts Inc

4.310
-0.070-1.60%

关于 Treace Medical Concepts Inc 公司

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Inc简介

公司代码TMCI
公司名称Treace Medical Concepts Inc
上市日期Apr 23, 2021
CEOTreace (John T)
员工数量477
证券类型Ordinary Share
年结日Apr 23
公司地址100 Palmetto Park Place
城市PONTE VEDRA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32081
电话19043735940
网址https://www.treace.com/
公司代码TMCI
上市日期Apr 23, 2021
CEOTreace (John T)

Treace Medical Concepts Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--

常见问题

Treace Medical Concepts Inc的前五大股东是谁?

Treace Medical Concepts Inc 的前五大股东如下:Mr. John K. Bakewell

有多少机构持有Treace Medical Concepts Inc(TMCI)的股份?

截至2026Q1,共有342家机构持有Treace Medical Concepts Inc的股份,合计持有的股份价值约为37.97M,占公司总股份的58.61%。与2025Q4相比,机构持股有所增加,增幅为-15683733.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有